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Preterm infants require considerably more protein to achieve normal intrauterine 
growth rates than is commonly fed to them during their first postnatal days. 
Continuing protein nutrition to maintain normal growth rates often is not achieved 
until several weeks after birth. Most very preterm infants do not receive the pro-
tein necessary to produce the 2−3 kilograms of body mass over a 12−16 week period 
of NICU care and, as a result, end up growth restricted by term, in lean body mass 
more than fat. This article reviews the requirements for protein and amino acids 
necessary to achieve normal growth and development of preterm infants. Protein 
requirements at 24−30 weeks’ gestation are as high as 4 g/kg/day, decreasing to 
2−3 g/kg/day by term. Individual amino acids are important not just as building 
blocks for protein synthesis and net protein balance, but also as essential signaling 
molecules for normal cellular function. Perhaps most importantly, brain growth and 
later life cognitive function are directly related to protein intake during the neona-
tal period in preterm infants. Data are reviewed that document successful increase 
in protein balance in preterm infants achieved with higher than usual rates of 
amino acid and protein nutrition, noting that positive protein balance requires at 
least 1.5 g/kg/day, but there still is increased protein balance up to 4 g/kg/day. 
Further research is necessary to determine optimal amounts and mixtures of pro-
tein and amino acids for both intravenous and enteral feeding to improve growth, 
development, and functional capacity of preterm infants. 
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1.  Introduction: Special Requirements 
for Nutrition of Preterm Infants
Medical care and survival of preterm infants, even 
those born as early as 24 weeks’ gestational age and 
as small as 500−600 g, have improved remarkably. 
As a result, a continuing and principal medical prob-
lem is the need to nourish these infants to achieve 
healthy growth, often as much as 2−3 kg of body 
mass over a 12−16 week period. While one objective 
of such nourishment is to achieve normal intrauterine 
growth rates as stated by the American Academy 
of Pediatrics,1 another is to produce healthy body 
composition and normally functioning cells, tissues, 
and organs.
2.  Are We Providing Sufficient Nutrition 
to Meet Such Needs?
Increase in body weight of preterm infants clearly 
is not the best measure of nutritional success, as it 
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ignores changes in body composition, and cell and 
organ development and function. Unfortunately, 
body weight remains the standard measure of neo-
natal nutrition; thus the true nutritional needs of 
preterm infants to optimize their growth and de-
velopment remain elusive.2,3 Recent data from the 
US National Institutes of Health Eunice Kennedy 
Shriver National Institute of Child Health and 
Development Neonatal Research Network4 show that 
preterm infants of nearly all early gestational ages 
still show postnatal growth delays. This is especially 
true for the smallest, most preterm infants who are 
taking longer and longer to start growing after their 
preterm birth, achieve normal rates of growth, and 
reach normal body size, even at term gestational age. 
Furthermore, growth in terms of achieving ideal body 
composition now is recognized as a major problem 
early in life, as most of these infants are fed more 
than sufficient energy for their energy expenditure, 
including for growth. Such excessive energy intake 
starts very soon after birth with relatively high rates 
of intravenous glucose and lipids as part of standard 
intravenous nutrition regimens. As a result, body fat 
content of growing preterm infants commonly ex-
ceeds that of normal in utero development.5 At the 
same time lean body mass is less well developed in 
these infants, evidence that considerably more amino 
acids and protein are required for growth of such 
tissues than these infants commonly have been fed 
and that excessive energy intakes do not produce 
more muscle and bone, only more body fat.6
Such underfeeding of amino acids and protein in 
preterm infants occurs despite a large and consist-
ent body of experimental evidence showing that in-
creasing amino acid and protein intakes, even during 
the first day of postnatal life and in infants who 
are requiring significant medical and often surgical 
treatments, produces increased net protein bal-
ance.7−10 Furthermore, early intravenous amino acid 
and enteral protein feeding shows evidence of en-
hanced growth, including early head circumference 
growth and later brain size and neurodevelopmental 
outcome.11,12 As such evidence expands and be-
comes more generalizable, it increasingly demon-
strates that increased nutrition, particularly of amino 
acids and protein, plays an essential role in improv-
ing growth and neurodevelopmental outcome of 
extremely preterm infants.
3.  Does It Matter Whether We Meet the 
Amino Acid and Protein Needs of 
Preterm Infants That Would Match 
Fetal Requirements?
As noted above, repeated observations have docu-
mented less than adequate growth of preterm 
infants.13 Furthermore, growth of lean body com-
ponents is particularly dependent on protein intake 
in organs such as the brain. Recent MRI studies have 
shown strikingly deficient growth of the brain by as 
much as 40% of total brain volume in preterm in-
fants,14,15 findings which are now evident even into 
adolescence.12,16 Such relatively gross measurements 
fail to show reduced development of neuronal length 
and dendritic connections, but these have been 
known for many years to occur in animal models of 
fetal under nutrition. For example, under nutrition 
of the rat fetus at critical stages of development per-
manently limits brain size, brain cell number, and 
dendritic number and interconnections. Perhaps 
more importantly, such under nutrition of rat fetuses 
also leads to reduced later life interactive behavior 
and cognitive functions such as learning and mem-
ory.17 Such adverse patterns of growth and devel-
opment are even more specific in regions of the 
brain, such as the caudate nucleus, that directly im-
pact cognition. Since a large proportion of preterm 
infants have some cognitive deficits, it is not sur-
prising that there is a direct relationship between 
the degree of under nutrition with its slower rates of 
growth and poorer cognitive function. Importantly 
for human and not just animal model development, 
recent studies indicate that very preterm infants, 
when fed more protein and energy, have remarkable 
capacity for improved growth, including that of the 
brain and essential regions in the brain that are 
particularly related to cognitive outcomes. Lucas’s 
group12 (noted above) followed their experimental 
cohort of preterm infants, first reported in the late 
1980s, into adolescence and was able to correlate 
directly the amount of nutrition provided to these 
infants with their adolescent body stature, brain 
and caudate nucleus size, and cognitive function, 
even at such a relatively advanced age and stage of 
development. More research in this area clearly is 
needed, however, as these observations were true 
only in males, and only for verbal IQ, not perform-
ance IQ. Furthermore, it was not clear whether the 
beneficial effects of the “high” nutrient diet were 
due to greater total nutrient intake, greater protein 
intake, more energy, or a greater supply of some es-
sential component, such as a particular amino acid 
(e.g., leucine) or a particular lipid (e.g., docosa-
hexanoic acid or DHA).
4.  Which Amino Acids and How Much 
Protein are Necessary for Normal 
Fetal Development?
Amino acids and protein are essential for produc-
ing normal fetal growth and development, provid-
ing the scaffolding for growth of all cells, tissues, 
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and organs, as well as the structural links among 
cells (e.g., dendrites among neurons). Amino acids 
in particular also act as metabolic signals to re-
gulate metabolism, especially to support growth. 
For example, both intravenous and dietary amino 
acids (particularly leucine and arginine), alone or 
in concert with glucose, stimulate insulin secretion, 
which augments amino acid stimulation of protein 
synthesis and protein accretion.18 Leucine also is 
an important oxidative substrate19 and arginine 
is the basic substrate for nitric oxide,20 which is 
important for vascular function and blood flow to 
growing organs. Essential amino acids also are fun-
damental for production of key regulatory prod-
ucts. Glutamate and serine and other non-essential 
amino acids, for example, uniquely promote pla-
cental and fetal metabolism.21,22 Less than normal 
supplies of amino acids to the fetus not only pro-
duce overall fetal growth restriction, but they also 
can result in life-long consequences of reduced 
muscle mass and short stature, as well as the likely 
potential for less than optimal growth of neural tis-
sue, neural connections, and cognitive development 
(Table 122).
5.  What Can We Learn From the Fetus 
About the Requirements for Amino 
Acid and Protein Nutrition?
A fundamental concept in nutrition of preterm in-
fants is that nutritional requirements for metabo-
lism and growth should at least match those of the 
healthy, growing fetus of the same gestational age. 
While there clearly are unique environmental im-
positions, medical and surgical interventions, and 
complicating diseases in preterm infants that might 
modify nutrient requirements, if a fetus requires a 
certain amount of protein to grow normal amounts of 
muscle and bone and other cells and tissues, then 
this should also be the goal for protein and amino 
acid nutrition in the preterm infant of the same ges-
tational age.
Studies in animal models have shown that the 
normally growing fetus is accustomed to large amino 
Table 1  Requirements for amino acids and protein 
during fetal development22
•  Growth: all tissues, particularly brain, muscle, and 
bone
•  Signals: protein synthesis, vascular development, 
insulin production
•  Unique (possibly essential) metabolic processes: 
glutamate production, serine production, non-
essential amino acid synthesis, etc.
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Figure 1 Data from fetal sheep at gestational ages 
equivalent to human fetuses of 20 weeks to term show-
ing increasingly high fractional rates of protein synthesis 
(KS, upper line) determined with leucine (closed circles) 
and lysine (open circles) radioactive tracers, compared 
with fractional growth rates (KG) at similar gestational 
ages (lower line). When scaled to human fetal growth 
rates, the fetal sheep data predict fetal amino acid 
requirements of 3.6−4.8 g/kg/d that bracket the 4 g/
kg/d requirement predicted by Ziegler et al26 using the 
factorial method for normal human fetal amino acid 
requirements to meet normal rates of fetal growth. 
Adapted from Meier et al23 and Kennaugh et al.24
acid uptake rates, certainly more than what is cus-
tomarily fed to the preterm infant of the same ges-
tational age. Such high amino acid uptake rates are 
necessary to support the uniquely high rates of frac-
tional protein synthesis and growth rates, as shown 
in Figure 123,24,26 for fetal sheep, which are several 
fold higher at gestational ages approximating that 
of 24−28 week preterm infants than they are at 
term.23,24 Amino acids are used for protein synthe-
sis in the fetus, and protein synthesis and net gain 
of protein are dependent on amino acid supply and 
fetal plasma amino acid concentrations.25 To meet 
these high rates of amino acid utilization for pro-
tein synthesis and growth, amino acids are actively 
transported into the fetus by the placenta in excess 
of amounts necessary just for net tissue accretion. 
Importantly, the excess amino acids not incorporated 
into net protein balance are used for oxidative me-
tabolism (energy production); in fact, amino acids 
are second only to glucose and its product lactate 
Protein for preterm infants 201
in their contribution to the consumption of oxygen 
for fetal energy production.19,27 As a result of such 
contributions to oxidative metabolism, rates of fetal 
urea synthesis and excretion normally are quite high, 
indicating that the same should be expected for 
preterm infants, including relatively higher plasma 
concentrations of urea nitrogen, who are fed suf-
ficient amino acids and protein to produce fetal 
rates of protein synthesis, growth, and oxidative 
metabolism.
Additionally, growth is a highly complex proc-
ess, not just one of producing more structural pro-
tein in cells and tissues, but of very high simultaneous 
rates of protein synthesis and protein breakdown. 
Interestingly, while more amino acids (as well as 
insulin and other anabolic growth factors) promote 
the synthesis of amino acids into protein, the high 
protein breakdown rates in the fetus are relatively 
resistant to suppression by additional amino acids 
or insulin. Furthermore, inadequate fetal nutrition 
leads to increased rates of protein breakdown. Thus, 
while growth is fundamental and requires large 
amounts of amino acids and protein nutrition for 
support, turnover of protein also is fundamental, 
allowing for the necessary remodeling of cells and 
tissues as they replicate, grow, and link together 
to form expanding tissues with increasingly inter-
dependent functions.
6.  What Happens After Birth to Amino 
Acid and Protein Metabolism and 
Nutrition?
Based on these observations of fetal amino acid 
and protein nutrition and their direct relation to 
fetal growth, does it matter whether amino acid 
and protein nutrition after birth is less than that of 
the normally growing fetus? First, all studies have 
shown that early postnatal provision of intravenous 
amino acids to preterm infants produces greater 
rates of protein synthesis and net protein balance.28 
This is true up to 3.5 g/kg of protein intake. Since 
most preterm infants are not fed as much protein 
as they would have received in utero by active 
placental transport of amino acids, it also is not 
surprising that nearly all preterm infants end up 
growth restricted at term gestation, whether de-
termined by fetal growth curves or postnatal cross 
sectional growth curves.29,30 Of more concern is 
the equally consistent observation that such slower 
than normal growth is associated with later life neu-
rodevelopmental delays and cognitive deficits.31 
Fortunately, follow up studies11 now are consist-
ently showing that early postnatal supply of amino 
acids and protein promote linear growth and growth 
of head circumference and a positive relationship 
between protein nutrition and neurodevelopmental 
outcome (see below).
7.  Why Are Preterm Infants Not Fed 
More Amino Acids and Protein in 
Their Early Postnatal Diets?
It appears that misunderstanding of normal metab-
olism (mostly ancient history at this point) has lim-
ited the amount of amino acids and protein in the 
diet of preterm infants, particularly immediately 
after birth. Some investigators refer to older stud-
ies by Goldman et al,32 who showed that extremely 
high protein intakes with formulas of less than 
optimal quality compared with milk and current 
formulas, produced metabolic acidosis, excessive 
ammonia concentrations, uremia, hyperaminoacide-
mia, growth restriction, and worse developmental 
outcome. Such observations, despite vast improve-
ments in formula compositions and generally im-
proved medical care of preterm infants, have carried 
over to current concerns for less than optimal amino 
acid metabolism, potential toxicity of individual 
amino acids, metabolic disorders such as uremia and 
metabolic acidosis, and the need for higher amounts 
of non-protein calories to support the use of amino 
acids for protein accretion. Recent research,10 how-
ever, has shown that such concerns are unfounded. 
The good news is that today preterm infants are 
in much better physiological condition than in the 
period of Goldman’s studies. Protein nutrient mix-
tures, especially those used intravenously, also are 
of much higher quality. Furthermore, even the high-
est rates of protein intake for preterm infants sug-
gested in new studies today are half or more of the 
rates of protein fed to the infants in Goldman’s stud-
ies. It is unlikely, therefore, that Goldman’s studies 
provide more than a warning about what can hap-
pen when reason gives way to unacceptably and irra-
tionally high protein intakes by anyone’s estimation.
7.1.  Possibility that amino acids will not be 
metabolized well
Regarding the concern that protein and amino acids 
are not well tolerated by preterm infants and will 
lead to growth restriction, actually, the opposite is 
true. Recent studies have shown that protein bal-
ance in near term33 and extremely low birth weight, 
very preterm infants (most of whom are on oxygen, 
ventilators, catecholamine infusions)10 is improved 
with adequate amino acid intake (see, for exam-
ple, Figures 2 and 3 from Thureen et al10) and there 
is a direct correlation between amino acid supply 
and protein balance through at least 3.0 g/kg/day 
(Figure 310).
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7.2.  Possibility that amino acids will not be 
oxidized well
There also has been concern that amino acids 
won’t be oxidized, leading to high, potentially toxic 
concentrations of amino acids. In preterm neonates, 
as in the fetus,34 however, amino acids are readily 
oxidized as fuels (Figure 310).
7.3.  Potential for toxic amino acid 
concentrations
Many have been concerned that higher amino acid/
protein intakes will produce excessively high concen-
trations of certain amino acids that are potentially 
toxic (e.g., glycine, phenylalanine, methionine). 
Others have been concerned that excessive intra-
venous amino acid intake won’t be as well tolerated 
because the quality (the balance or mix of individ-
ual amino acids) of intravenous (IV) amino acid 
mixtures is not good enough. This would lead to 
an imbalance of levels causing decreased protein 
synthesis, interference with amino acid transport, 
abnormal brain/CSF concentrations that in turn 
might adversely affect neurotransmitters, and ac-
cumulation of toxic metabolites. In contrast, recent 
measurements of amino acid concentrations in pre-
term infants fed modern IV amino acid mixtures 
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Figure 2 Amino acid intake (expressed as protein 
intake), urinary nitrogen excretion (expressed as protein 
excretion), and resulting protein balance at low (1 g/g/d) 
and high (3 g/kg/d) amino acid intakes. Values expressed 
as mean ± standard error of the mean. Reproduced with 
permission from Thureen et al.10
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Figure 3 By regression analysis, there was significant cor-
relation between leucine intake rate and leucine oxidation 
rate. Adapted from Thureen et al.10
have lower concentrations of potentially toxic amino 
acids10,35 and, in fact, have concentrations of most 
amino acids approximating those found in normally 
growing, healthy human fetuses in both second 
and third trimesters from umbilical vein samples 
(Figure 410,36). However, concentrations of some 
essential amino acids, particularly lysine and thre-
onine, both essential amino acids and thus regula-
tory for protein synthesis rates, still are less than 
normal fetal values (Figure 410,36) when fed IV with 
a common commercial IV amino acid mixture used 
in the USA. It is possible, therefore, that even fur-
ther improvement in the quality of intravenous amino 
acid mixtures will promote better amino acid bal-
ance and improved growth. This improvement also 
might extend to enteral feedings as formula manu-
facturers continue to optimize protein quality in for-
mulas and milk fortifiers (the latter aided by the 
need for developing simple, accurate, rapid, and 
inexpensive measures of protein concentration in 
human milk).
7.4. Possibly excessive uremia
Many also are concerned that higher amino acid/pro-
tein intakes in preterm infants will lead to excessive 
uremia and that uremia will cause harm to these 
infants. Such fear of uremia probably reflects very 
old experience with IV and enteral amino acid and 
protein mixtures that were not of appropriate qual-
ity for these infants. Many more such infants were 
in much worse physiological condition, receiving 
inadequate energy intakes to provide alternative 
oxidative substrate and having worse renal blood 
flow and glomerular and tubular function, than is 
the case for the majority of preterm infants today. 
Urea production normally is very high when there 
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are high rates of amino acid oxidation, which in-
creases urea synthesis and excretion rates. The 
normal sheep fetus, for example, excretes approx-
imately 800 mg/kg/day of urea, which is about 
equal to 100 mg N/kg/day or about 2.4 g/kg/day of 
amino acids.37 Similarly, the normal human newborn 
infant at term metabolizes less amino acids (per 
kg body weight) than very preterm infants, yet de-
velops quite high urea excretion rates of about 
600 mg/kg/day or about 80 mg N/kg/day (approxi-
mately 1.9 g/kg/day of amino acids).37
Furthermore, there is no credible evidence that 
uremia of the degree commonly seen in preterm 
infants causes harm (an interesting study, in fact, 
would be to correlate blood urea nitrogen (BUN) 
concentrations in preterm infants with neuronal 
development and neurological and cognitive out-
comes). Also, a recent study38 showed that among 
the usual type of preterm infant, including extremely 
low birth weight infants with less than 1000 g in birth 
weight and 27 weeks’ gestational age, there was 
no correlation between amino acid intake and BUN 
and there were very few BUN values greater than 
40 mg/dL. In fact, BUN only increased modestly 
(around 5 mg/dL) when amino acid intake was 
nearly tripled from around 1 g/kg/day to around 3 g/
kg/day, which it should do, since amino acids are 
normal oxidative substrates19,34 that yield ammonia, 
the source of urea, as well as CO2 (Figure 538).
7.5.  Potential for metabolic acidosis
Still others are concerned that excessive amino acid 
and/or protein intake can lead to metabolic acido-
sis. Most studies have not shown metabolic acidosis 
in preterm infants fed relatively higher rates of 
amino acids (Table 28,10,39,40). When such acidosis 
Table 2  Randomized trials of early amino acid admin-
istration in very low birth weight infants8,10,39,40
Van Lingen et al, 199239
 2.3 g/kg/d vs. control at beginning at 24 hr
 Normal BUN, no difference in pH, or base excess
Rivera et al, 19938
 1.5 g/kg/d vs. glucose within 24 hr
 No differences in BUN, ammonia, or CO2 content
Van Goudoever et al, 199540
 1.15 g/kg/d vs. glucose immediately after birth
 No differences in BUN, pH, or base excess
Thureen et al, 200310
 1 g/kg/d vs. 3 g/kg/d
 No difference in BUN, or base excess
BUN = blood urea nitrogen.
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Figure 5 Blood urea nitrogen (BUN) correlates poorly with 
amino acid intake (data in < 1000 g birth-weight infants). 
Reproduced with permission from Ridout et al.38 does occur, usually there are other reasons, such as 
reduced glomerular filtration rate and urine flow 
rate, severe fluid restriction as often done for hyper-
glycemia, or the opposite, dilutional acidosis from 
excessive fluid administration (Table 28,10,39,40).
7.6.  Need for higher caloric intake to 
metabolize the amino acids
There are also those who continue to falsely as-
sume that increasing energy intakes must accom-
pany increasing amino acid/protein intakes or the 
amino acids and protein will not be incorporated 
into net protein growth. This is true only at lower 
non-protein caloric intakes of below 60 kcal/kg/
day. Above that level, increased protein intake is 
the primary determinant of protein gain, while in-
creased non-protein calorie intake (fat and carbo-
hydrate) primarily enhances growth of body fat.41 
Furthermore, in one study42 it was noted that in-
creased energy intake improved nitrogen retention 
by enhancing amino acid reutilization for protein 
synthesis, a higher quality protein improved nitro-
gen retention by limiting protein breakdown, em-
phasizing the primary of importance of protein for 
producing nitrogen retention and positive protein 
balance. Excessive caloric intake, therefore, does to 
a preterm infant just what it does to everyone—
produces excess fat.
8.  But There Always Is Reason for 
Caution
Infants with documented excessive uremia probably 
should have their energy intakes, and cardiovascu-
lar and renal systems improved before they are ad-
vanced beyond the minimum amount of amino acids 
(approximately 1.5 g/kg/day) needed to prevent 
Protein for preterm infants 205
protein breakdown. In fact, excessive feeding of 
all substrates needs to be questioned when abun-
dant data demonstrate increased hyperglycemia 
from too much glucose and obesity from too much 
energy (lipid plus glucose), as well as the now widely 
recognized concern that excessive weight gain, pri-
marily of adiposity (and primarily abdominal adipos-
ity that is characteristically found in overfed infants 
with growth restriction and infants of diabetic moth-
ers), might lead to later life complications of obes-
ity, insulin resistance, and Type 2 diabetes. These 
problems of obesity and diabetes have reached 
epidemic proportions internationally. Interestingly, 
however, there is little data yet that shows that 
overfed preterm infants who gain excess fat expe-
rience adverse outcomes of obesity and diabetes 
more than the average infant, unless their excessive 
weight gain continues beyond 6 months to 1 year of 
life.43 There also is no evidence that simply meet-
ing the growth requirements of amino acids for pre-
term infants has any bearing on the adverse effects 
of overfeeding that probably are more related to 
excessive caloric intake and the earlier develop-
ment of obesity.
Nevertheless, there have been examples from ex-
cessively high amino acid and protein administra-
tion to preterm infants that have shown significant 
problems of metabolic acidosis, growth failure, and 
reduced neurodevelopmental outcome. Further-
more, attempts to prevent or correct fetal under 
growth with maternal high protein diets actually in-
creases fetal intrauterine growth restriction and fetal 
and neonatal mortality rates, which also can lead to 
reduced insulin secretion as adults. Mater nal high 
protein diets can increase fetal intrauterine growth 
restriction and fetal and neonatal mortality rates and 
lead to reduced insulin secretion when such infants 
become adults. Recently, follow-up studies of off-
spring of pregnant women who were fed either a 
high protein, low carbohydrate diet or a “standard” 
diet44,45 showed that the group that ate the high 
protein/low carbohydrate diet produced infants who, 
as adults (now in their late 30s), have higher blood 
pressure, fasting blood glucose concentrations, 
plasma cortisol concentrations, and hypothalamic-
pituitary axis activity, and they were more obese. 
Too much of a good thing is not always better!
How much protein is too much, however, still has 
not been determined, although current estimates 
are that this limit might be around 4 g/kg/day for 
preterm infants born around 24−28 weeks of gesta-
tion, while more mature infants progressively re-
quire less as their gestational age approaches term. 
Furthermore, there is clear evidence that overfeed-
ing of non-protein calories produces more rapid than 
normal gain of weight at any gestational age; this 
largely is due to fat deposition in adipose tissue, 
which increases the risk of later life obesity, insu-
lin resistance, and diabetes. There are limits to all 
nutrient supplies.
9.  How Should We Feed Amino Acids 
and Protein to Preterm Infants?
Preterm infants need to be fed enough amino acids 
and protein, starting right after birth, to prevent 
protein breakdown and to promote the growth and 
remodeling of cells, tissues, and organs at rates 
and producing body composition of lean body mass 
that mimic the growth and body composition of 
healthy fetuses growing in utero. This means provid-
ing amino acids and proteins earlier and in greater 
amounts after birth than customarily have been 
provided. IV amino acids should be provided start-
ing as soon after birth as possible at rates ap-
propriate for gestational age: 3.5−4.0 g/kg/day for 
infants < 30 weeks’ gestational age; 2.5−3.5 g/kg/
day for infants > 30 but < 36 weeks’ gestational age; 
2.5 g/kg/day for infants > 36 weeks’ gestational age. 
IV amino acid infusion rates can be tapered as en-
teral feedings advance, keeping total protein in-
takes at the starting values until growth develops 
and protein requirements can be re-evaluated. As 
long as the amounts of amino acids and protein are 
supplied at rates necessary to support protein syn-
thesis and net protein gain, adverse consequences 
of both too little and too much protein can be 
avoided.
Milk is considered highly desirable for feeding 
preterm infants, but generally needs supplements 
with protein and other nutrients. For example, es-
timates of milk protein content, with and without 
supplements, often are less than the measured pro-
tein content, leading to protein intakes that can be 
as much as 0.6−0.8 g/kg/day less than estimated.46 
Without more accurate measurements of milk pro-
tein content, therefore, assumed protein intake in 
infants fed milk (supplemented or not) can signifi-
cantly overestimate actual protein intake. To com-
pensate for the limitation in protein intake in such 
milk-fed infants, one group has recommended the 
simple addition of 1 g of protein (as a high quality 
liquid or powder supplement) per 100 mL of milk to 
arbitrarily, but reasonably, increase protein con-
tent of supplemented or unsupplemented milk and 
thus protein intake.47
Very few studies actually have addressed whether 
protein supplements per se do promote growth in 
preterm infants. The NICHD Neonatal Research 
Network11 and the Pediatrix organization48 at-
tempted to address this issue by comparing growth 
in infants fed more protein a few days earlier in 
one group vs. another group. While these studies 
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did not show significantly improved growth in the 
group fed more amino acids earlier, they did not 
show adverse effects, similar to the many studies 
of providing greater amounts IV amino acids to such 
preterm infants and observing a consistent increase 
in protein balance. It still remains fundamental, 
therefore, that growth of lean body mass — muscle, 
bone, brain, and organ mass — cannot increase with-
out more protein, since these structures are built 
on a protein matrix.
10.  Conclusions and Suggestions for 
Further Research
Further studies are needed to determine and de-
velop optimal mixtures of amino acids for both in-
travenous and enteral feeding, as well as optimal 
amounts of total amino acids and protein. Glucose 
and lipid intakes need to meet energy expenditure 
requirements, but this generally will mean providing 
less of these substrates than these infants usually 
receive. For glucose, maintaining normal glucose 
concentrations that match those of the normally 
growing fetus (> 50 mg/dL, < 80 mg/dL) might be im-
portant for neurodevelopment.49 Polyun saturated 
fatty acids of the ω-3 variety, particularly relative 
to amounts of ω-6 fatty acids, might be more ben-
eficial for neurodevelopment as well.50 Future stud-
ies also are needed to determine long term outcomes 
of different rates of growth of different body com-
ponents, such as adipose tissue and muscle, and 
include evidence for the rate of development of 
obesity, insulin resistance, and diabetes, as well as 
much needed information on brain growth (cellular 
as well as overall volume) and neuronal, neurolog-
ical, and cognitive outcomes. When coupled with 
other studies and reports that are showing little if 
any adverse metabolic complications, it appears 
that there is more than sufficient rationale for pro-
moting new research and clinical practice to de-
fine the short and long term benefits (and risks) of 
more optimal nutrition of preterm infants, nutrition 
that actually meets the requirements for growth 
as well as maintenance metabolism of these very 
small infants, right after birth.
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